Cyclacel Pharmac Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 27.98 K | $41.42 K | 100.00% | 1.28% |
| DRW SECURITIES, LLC | 02/12/2026 | 24.86 K | $36.79 K | 100.00% | 1.14% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 22.60 K | $33.45 K | 100.00% | 1.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 3.01 K | $4.45 K | 181.03% | 0.14% |
| UBS GROUP AG | 01/29/2026 | 584 | $864 | 1,360.00% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2 | $3 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 2 | $3 | -33.33% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 1 | $1 | 0.00% | 0.00% |
| ARCHER INVESTMENT CORP | 01/30/2026 | 1 | $1 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclacel Pharmac institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Cyclacel Pharmac. The most heavily invested institutionals were:
TWO SIGMA SECURITIES, LLC: 27,984
DRW Securities, LLC: 24,857
RENAISSANCE TECHNOLOGIES LLC: 22,600
Tower Research Capital LLC (TRC): 3,007
BANK OF AMERICA CORP /DE/: 2
ADVISOR GROUP HOLDINGS, INC.: 1
3.62% of Cyclacel Pharmac stock is owned by institutional investors.
Institutional investors have bought a total of 102.32 K shares in the last 24 months. This purchase volume represents approximately $651.75 K in transactions.